CliffBio
small molecule

HYDERGINE LC

ERGOLOID MESYLATES

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDERGINE LC
Active ingredientERGOLOID MESYLATES
Strength1MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1983
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.